Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01022840Phase 3Completed
Phase 3, randomised, double-blind trial of esketamine in postoperative pain (3 arms), sponsored by Medical University of Graz. Primary endpoint: Postoperative opioid consumption at 1 year. Started Feb 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01022840.